Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-07

Clinical Trial Update: Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting on the efficacy of Ginkgo Biloba Extract for Alzheimer's disease across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Alzheimer's | Phase 2, Phase 3 | Status: UNKNOWN